Login / Signup

Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.

Zehua WangJianwen GaoYuko OhnoHaiou LiuCong-Jian Xu
Published in: Cancer chemotherapy and pharmacology (2020)
Rosiglitazone combined with olaparib can help manage ovarian cancer by ameliorating olaparib-induced senescence and improving anti-tumor effects.
Keyphrases
  • endothelial cells
  • dna damage
  • high glucose
  • oxidative stress
  • stress induced
  • diabetic rats
  • endoplasmic reticulum stress
  • cell death
  • cell cycle arrest
  • drug induced